Facius, Axel
Marostica, Eleonora
Gardiner, Philip
Watz, Henrik
Lahu, Gezim
Funding for this research was provided by:
Takeda Pharmaceuticals International GmbH, Zurich, Switzerland
AstraZeneca, Cambridge, UK
Article History
First Online: 25 May 2018
Compliance with Ethical Standards
:
: This study was funded by Takeda Pharmaceuticals International GmbH, Zurich, Switzerland; AstraZeneca, Cambridge, UK, are the current study sponsors.
: Henrik Watz has received consulting fees and payment for lectures from Takeda and AstraZeneca. He has received support for travel to meetings for the study and manuscript preparation from AstraZeneca, and provided writing assistance to AstraZeneca. Philip Gardiner is an employee of AstraZeneca. Axel Facius was employed as pharmacometrician at Takeda Pharmaceuticals, who executed the studies reported in this manuscript. He further received travel support from AstraZeneca for the ATS2017 conference, where parts of the current manuscript were presented. Gezim Lahu was employed by Takeda, who executed the studies reported in this manuscript. Eleonora Marostica was a paid consultant for Takeda.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study. Additional informed consent was obtained from all individual participants for whom identifying information is included in this article.